[
  {
    "ts": null,
    "headline": "Baxter International Stock: Is BAX Underperforming the Health Care Sector?",
    "summary": "Baxter International has lagged the broader health care sector by a wide margin over the past year, and analysts are taking a guarded stance on its outlook.",
    "url": "https://finnhub.io/api/news?id=7d18c22ed204b36d0259d2139f52d08e7c6723bf7203f538eee1bf6ed63dd279",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765529363,
      "headline": "Baxter International Stock: Is BAX Underperforming the Health Care Sector?",
      "id": 137767326,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Baxter International has lagged the broader health care sector by a wide margin over the past year, and analysts are taking a guarded stance on its outlook.",
      "url": "https://finnhub.io/api/news?id=7d18c22ed204b36d0259d2139f52d08e7c6723bf7203f538eee1bf6ed63dd279"
    }
  },
  {
    "ts": null,
    "headline": "Is Baxter International Offering Long Term Value After Years of Share Price Declines?",
    "summary": "Wondering if Baxter International is a beaten down healthcare name or a genuine value opportunity at today’s price? Let’s unpack what the market might be missing. The stock has inched up 2.3% over the last week and 3.6% over the past month, but that is against a much steeper backdrop with returns of -35.4% year to date and a -74.0% slide over five years. Investors have been reacting to Baxter’s ongoing portfolio reshaping, including moves to streamline its medical products business and...",
    "url": "https://finnhub.io/api/news?id=259682b483230657db0647b987ea234464d797ca0b6e86ddc94c9ef4b245615e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765498487,
      "headline": "Is Baxter International Offering Long Term Value After Years of Share Price Declines?",
      "id": 137767327,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Wondering if Baxter International is a beaten down healthcare name or a genuine value opportunity at today’s price? Let’s unpack what the market might be missing. The stock has inched up 2.3% over the last week and 3.6% over the past month, but that is against a much steeper backdrop with returns of -35.4% year to date and a -74.0% slide over five years. Investors have been reacting to Baxter’s ongoing portfolio reshaping, including moves to streamline its medical products business and...",
      "url": "https://finnhub.io/api/news?id=259682b483230657db0647b987ea234464d797ca0b6e86ddc94c9ef4b245615e"
    }
  }
]